Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks

• Sidonie Lambert-Niclot ,

  * E-mail: sidonie.lambert@psl.aphp.fr

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Philippe Flandre,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Marc-Antoine Valantin,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Cathia Soulie,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Slim Fourati,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Marc Wirden,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Sophie Sayon,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Sophie Pakianather,

  Affiliation INSERM U 943, Paris, France

  ⨯
• Laurence Bocket,

  Affiliation CHRU de Lille, Virology, Lille, France

  ⨯
• Bernard Masquelier,

  Affiliation AP-HP, Pellegrin Hospital, Bordeaux, France

  ⨯
• Georges Dos Santos,

  Affiliation Centre Hospitalier et Universitaire de Fort-de-France, Fort de France, Martinique, France

  ⨯
• Christine Katlama,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Vincent Calvez,

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯
• Anne-Genevieve Marcelin

  Affiliation AP-HP, Pitié-Salpêtrière Hospital, INSERM U 943 and Pierre et Marie Curie University Paris, Paris, France

  ⨯